Clinical Trial Update: Role of Plavix in Hemorrhagic and Ischemic Complications of Catheterization. [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the role of clopidogrel (Plavix) in hemorrhagic and ischemic complications during catheterization; the study (NCT00421252) sponsored by…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Myocardial Ischemia

Drugs mentioned

• Plavix (clopidogrel)

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Coronary Artery Disease, Myocardial Ischemia | Phase 4 | Status: TERMINATED